ArticleFrontiers in immunology2022

Epigenetic-related gene mutations serve as potential biomarkers for immune checkpoint inhibitors in microsatellite-stable colorectal cancer.

Chao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.